Company / Working Capital
Maze Therapeutics, Inc. Working Capital History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$327.2M
FY2025
5-year range
$327.2M / $327.2M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#131 of 213
Health Care
What the data says
At $327M, Maze Therapeutics, Inc.'s working capital ranks #131 of 213 in the Health Care sector.
Based on SEC 10-K filings.
$327M in FY2025.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#131 of 213 in Health CareTop 62% of 213This company $327.2M Sector average $934.6M
▼
-65.0% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $327.2M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026